Results 191 to 200 of about 7,229 (203)

Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia

HIV Clinical Trials, 2016
Ploenchan Chetchotisak, Siriluck Anunnatsiri   +1 more
exaly  

Amiodarone/rilpivirine

Reactions Weekly
openaire   +1 more source

Pantoprazole/rilpivirine interaction

Reactions Weekly, 2015
openaire   +1 more source

Abacavir/lamivudine//rilpivirine

Reactions Weekly, 2018
openaire   +1 more source

Characterization of a case of virological failure after switch to long-acting cabotegravir and rilpivirine

Journal of Antimicrobial Chemotherapy
Saverio Giuseppe Parisi, Maria Mazzitelli, Annemarie M J Wensing   +2 more
exaly  

Dolutegravir/lamivudine/rilpivirine

Reactions Weekly, 2019
openaire   +1 more source

Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.

Open Forum Infectious Diseases
François R Girardin, Catia Marzolini, Monia Guidi   +2 more
exaly  

PROCESS FOR RILPIVIRINE

2012
PARTHASARADHI REDDY BANDI, RATHNAKAR REDDY KURA, MURALIDHARA REDDY DASARI, VENKAT NARSIMHA REDDY ADULLA, VAMSI KRISHNA BANDI   +4 more
openaire   +2 more sources

RILPIVIRINE PROCESS

2014
GURJAR MUKUND KESHAV, MAIKAP GOLAKCHANDRA SUDARSHAN, JOSHI SHASHIKANT GANGARAM, BADHE SACHIN ARAVIND, MEHTA SAMIT SATISH   +4 more
openaire   +1 more source

Cabotegravir/Rilpivirine/Testosterone

Reactions Weekly
openaire   +1 more source